Zura Bio Limited
Price Action
Technical Summary
EMERGING TRENDZura Bio Limited shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 85), indicating clear outperformance against the broad market. Earnings contraction of 250% provides fundamental context to the price action. Investors should exercise caution due to high volatility (109% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $5.43 | -9.82% | BELOW |
| 50 SMA | $5.93 | -17.55% | BELOW |
| 100 SMA | $5.69 | -14.04% | BELOW |
| 150 SMA | $5.06 | -3.37% | BELOW |
| 200 SMA | $4.28 | +14.39% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ZURA in an uptrend right now?
ZURA has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is ZURA overbought or oversold?
ZURA's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is ZURA outperforming the market?
ZURA has a Relative Strength (RS) Rating of 85 out of 99. Yes, ZURA is a market leader, outperforming 85% of all stocks over the past 12 months.
Where is ZURA in its 52-week range?
ZURA is trading at $4.89, which is 66% of its 52-week high ($7.44) and 61% above its 52-week low ($0.98).
How volatile is ZURA?
ZURA has a Beta of 1.88 and 52-week volatility of 109%. It's more volatile than the S&P 500 - expect bigger swings.